Hint mode is switched on Switch off
For swift navigation between sections

Sansure Biotech

PDF download

Choose all Reset all
Download Cancel
Organization name
Sansure Biotech Inc
Country name
China
Country of registration
China
Industry
Medical Devices
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Sansure Biotech Inc. develops and sells upstream nucleic acid extraction kits, real time PCR diagnostic and research kits, and fluorescence systems in China and internationally. The company offers novel coronavirus nucleic acid diagnostic kits; viral hepatitis and AIDS, blood screening, and extraction kits; cancer-related biomarkers; and kits for respiratory tract diseases, STDs, digestive tract diseases, prenatal and postnatal care, and genetic diseases, as well as instruments and other consumables. It serves hospitals and laboratories. The company was founded in 2008 and is based in Changsha, China.

Awards

News

26/02/2025 Sansure Biotech to Acquire 54% Stake in Hong'an Jiyuan Biotechnology
25/02/2025 Sansure Biotech Completes Acquisition of Zhongshan Haiji
14/01/2025 Sansure Biotech to Acquire 100% Stake in Diagnostic Company
All organization news

Documentation

Stocks

Public debt by currencies

Show more Hide

Codes

  • SIC
    2835 IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Registration is required to get access.